Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elicera Therapeutics' abstract on the iTANK platform's potential to enhance CAR T-cell treatment of solid tumors accepted for presentation at ISCT 2024

Gothenburg, February 16, 2024 – Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation cancer treatments based on its proprietary commercial technology platform iTANK, announces today that the company has been invited to present at the scientific conference International Society for Cell & Gene Therapy (ISCT) Meeting 2024 in Vancouver, Canada, May 28 to June 1.Margareth Jorvid, board member of Elicera Therapeutics, will participate in a networking session to present the company's scientific abstract entitled "The iTANK platform has

Nomination committee for the 2024 Annual General Meeting

According to the resolution of the 2023 Annual General Meeting, the Nomination Committee shall be convened by the Chairman of the Board and consist of a representative of each of the three largest shareholders in terms of the number of votes at the end of December 2023.At the end of December, the three largest shareholders were Cadila Pharmaceuticals Ltd. and Fårö Capital AB and SEB Fonder. All have agreed to participate in the nomination committee's work. Prior to the 2024 Annual General Meeting, the Nomination Committee consists of Christer Fåhraeus (appointed by Fårö Capital AB),

Invitation to the presentation of Arla Plast´s year-end report 2023 at 10:00 am (CET) on 22 February, 2024

Arla Plast will release the year-end report for 2023 on Thursday 22 February, 2024 at 08:00 am (CET).Christian Krichau, President and CEO, and Monica Ljung, CFO, will present the financial result on a digital conference the same day at 10:00 am (CET). The report and a presentation will be available on www.arlaplastgroup.com. In order to participate in the conference, please send an email that you would like to attend to ir@arlaplast.com and you will receive a link. For further information, please contact: Monica Ljung, CFO, tel: 0141-20 38 02 Christian Krichau, CEO, tel: 0141-

Lumera appoints Jonas Alfredson acting CEO

Lumera’s CEO Mats Lillienberg has elected to retire. During the search for his successor, CFO Jonas Alfredson will step in as acting CEO.Stockholm, February 16, 2024 – The Board of the insurtech company Lumera has appointed Jonas Alfredson acting CEO. Mats Lillienberg, CEO of Lumera AB since 2018, will leave the company as he is retiring.During the fall of 2023, Mats Lillienberg informed the Board of his intent to retire. The search process for a new CEO is already underway, but it is unclear when this will be completed. A joint decision has now been made where Mats promptly resigns,

Invitation to Spinnova’s Capital Markets Day 2024

SPINNOVA PLC, PRESS RELEASE, 16 February 2024, 11:00 a.m. EET Invitation to Spinnova’s Capital Markets Day 2024 Spinnova is pleased to invite investors and analysts to its Capital Markets Day on 14 March 2024. The event will be held in Spinnova’s premises at Eteläportintie 15, Jyväskylä. The Capital Markets Day can also be followed via a live webcast. Date: Thursday, 14 March 2024Time: 14.00 – approx. 17.00 EET Location: Spinnova premises, Eteläportintie 15, 40530 Jyväskylä and online Webcast: https://spinnova.videosync.fi/2024-cmd During the event, Spinnova’s CEO Tuomas

Invitation to Nanoform’s Q4 and FY 2023 Report Presentation

Press release Nanoform Finland Plc February 16, 2024 11:00 a.m. Finnish time / 10:00 a.m. Swedish time Invitation to Nanoform’s Q4 and FY 2023 Report Presentation Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, will publish its Q4 and FY 2023 report on February 29, 2024, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold an online presentation and conference call the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be represented by CEO Edward Hæggström, CFO Albert Hæggström

United Bankers Plc’s Financial Statements Bulletin 2023: Record profit supported by new strategic funds

United Bankers Plc’s Financial Statements Bulletin 2023: Record profit supported by new strategic fundsJanuary-December 2023 in brief · The Group’s revenue (income from operations) in the financial period amounted to EUR 52.1 million (EUR 48.6 million in 1–12/2022). · The Group’s adjusted EBITDA amounted to EUR 19.1 million (EUR 18.5 million in 1–12/2022) and adjusted operating profit to EUR 16.9 million (EUR 16.6 million in 1–12/2022). · The profit for the financial period amounted to EUR 13.8 million (EUR 12.9 million in 1–12/2022). · Earnings per share were EUR 1.24 (EUR 1.

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 37 – 16 FEBRUARY 2024  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Nomination Committee Board Proposals for 2024

To the Annual General Meeting (AGM) on May 14, 2024, the Nomination Committee of Ependion AB has informed the company that it will be proposing following:· that the Board of Directors shall consist of five members. · re-election of Board members Johan Wester, Karin Gunnarsson, Lars Eklöf and Jonas Hård. Bo Elisson has declined re-election. Charlott Samuelsson has, for personal reasons, also declined re-election. · new election of Peter Nilsson. · election of Peter Nilsson as Chairman of the Board. · election of Bo Elisson as the Chairman of the Meeting.    Peter Nilsson,

Australia’s Intermodal Terminal Company orders seven electric Konecranes RMG cranes for new Melbourne freight facility

Intermodal Terminal Company (ITC) has ordered seven Konecranes Rail Mounted Gantry (RMG) cranes for its new Somerton terminal in north Melbourne, Australia, to support its ambitious national growth plans. The delivery also includes seven Konecranes Remote Operating Stations (ROSs). Delivery will take place between April and September 2025. The order was booked in December 2023. Wholly owned and backed by Aware Super, one of Australia’s leading superannuation funds managing $170 billion on behalf of its 1.1 million members, the ITC aims to assemble a national portfolio of terminals with

Mandatum plc: Managers' Transactions (Lapveteläinen)

Mandatum plc, Stock exchange release / Managers’ transactions, 16 of February 2024 at 10:00 a.m. EET Mandatum Oyj - Managers' Transactions – Lapveteläinen Mandatum plc (Business ID 3355142-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the demerger plan approved by Sampo plc’s Annual General Meeting on 17 May 2023. _________________________________ Person subject to the notification requirement Name: Patrick Lapveteläinen Position: Member of the Board/Deputy member Issuer: Mandatum

Mandatum plc: Managers' Transactions (Laaksonen)

Mandatum plc, Stock exchange release / Managers’ transactions, 16 of February 2024 at 10:00 a.m. EST Mandatum Oyj - Managers' Transactions – Laaksonen Mandatum plc (Business ID 3355142-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the demerger plan approved by Sampo plc’s Annual General Meeting on 17 May 2023. _________________________________ Person subject to the notification requirement Name: Kimmo Laaksonen Position: Member of the Board/Deputy member Issuer: Mandatum Oyj

Mandatum plc: Managers' Transactions (Fagerholm)

Mandatum plc, Stock exchange release / Managers’ transactions, 16 of February 2024 at 10:00 a.m. EET Mandatum Oyj - Managers' Transactions – Fagerholm Mandatum plc (Business ID 3355142-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the demerger plan approved by Sampo plc’s Annual General Meeting on 17 May 2023. _________________________________ Person subject to the notification requirement Name: Jannica Fagerholm Position: Member of the Board/Deputy member Issuer: Mandatum Oyj

Publication of Solwers' Financial Statements 2023 Release and invitation to webcast

Solwers Plc Press release 16 February 2024 at 10:00 am EEST Solwers will publish its Financial Statements Release for January–December 2023 on Wednesday, 28 February, approximately at 09.00 am EEST. When published, the Financial Statements Release will be available in Finnish and English on the company’s website at www.solwers.com. CEO Stefan Nyström and CFO Teemu Kraus will present the company’s result in a live English webcast on the same day, starting at 10:00 am EEST. The webcast can be followed by registering at https://solwers.videosync.fi/financial-statement-release2023/

Qlife reports first milestone achieved and on track with Chinese collaboration

UPDATE: Qlife has previously reported the potential of its Chinese collaboration and is now updating accordingly: Qlife’s collaboration with Hipro Biotechnology to bring home-hospital blood biomarker testing into the Chinese market and elsewhere – is progressing according to plan and has been further expanded with a focus on additional biomarker tests.The collaboration consists of four major parts: 1. Integration of reagents 2. Regulatory approval in China 3. Distribution and sales in China 4. Production of Egoo in China Integration of reagents The parties have worked

Mandatum plc: Managers' Transactions (Ruuska)

Mandatum plc, Stock exchange release / Managers’ transactions, 16 of February 2024 at 10:00 a.m. EST Mandatum Oyj - Managers' Transactions – Ruuska Mandatum plc (Business ID 3355142-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the demerger plan approved by Sampo plc’s Annual General Meeting on 17 May 2023. _________________________________ Person subject to the notification requirement Name: Jukka Ruuska Position: Member of the Board/Deputy member Issuer: Mandatum Oyj LEI:

Mandatum plc: Managers' Transactions (Aho)

Mandatum plc, Stock exchange release / Managers’ transactions, 16 of February 2024 at 10:00 a.m. EST Mandatum Oyj - Managers' Transactions – Aho Mandatum plc (Business ID 3355142-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the demerger plan approved by Sampo plc’s Annual General Meeting on 17 May 2023. _________________________________ Person subject to the notification requirement Name: Markus Aho Position: Member of the Board/Deputy member Issuer: Mandatum Oyj LEI:

Mandatum plc: Managers' Transactions (Lamminen)

Mandatum plc, Stock exchange release / Managers’ transactions, 16 of February 2024 at 10:00 a.m. EET Mandatum Oyj - Managers' Transactions – Lamminen Mandatum plc (Business ID 3355142-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with the demerger plan approved by Sampo plc’s Annual General Meeting on 17 May 2023. _________________________________ Person subject to the notification requirement Name: Johanna Lamminen Position: Member of the Board/Deputy member Issuer: Mandatum Oyj

Ericsson to utilize mandate to transfer shares

Ericsson’s (NASDAQ:ERIC) annual general meeting on March 29, 2023 authorized the company’s board of directors to resolve on the transfer of the company’s own shares. Under the authorization the company may, in conjunction with the delivery of vested shares under the long-term variable compensation programs 2019 and 2020 (“LTV 2019” and “LTV 2020”), prior to the annual general meeting in 2024, decide to retain and sell no more than 60% of the vested shares of series B in the company in order to cover for the costs for withholding and paying tax and social security liabilities on behalf of

Enzymatica’s rights issue is secured to 100 percent

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE THE UNITED STATES OF AMERICA, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR INVOLVE REQUIREMENTS FOR MEASURES OTHER THAN WHAT FOLLOWS BY SWEDISH LAW. The Board of Directors of Enzymatica AB (publ) (”Enzymatica” or ”the Company”) decided on February 16, 2024, to carry out a rights issue of SEK 27.4 million with preferential rights for existing shareholders. The Board of

AutoStore Holdings Ltd. - Mandatory notification of trade

(Nedre Vats, 16 February 2024): With reference to the stock exchange announcement made earlier today, AutoStore Holdings Ltd. ("AutoStore") has been notified of PDMR trades made by funds associated with Thomas H. Lee Partners LP ("THL"). THL is represented on the board of directors of AutoStore and are considered as closely associated with James C. Carlisle (chair of the AutoStore board of directors) and Michael M. Kaczmarek (AutoStore board member). Notifications for transactions by close associates are enclosed to this announcement. This information is subject to the disclosure

Rightbridge Ventures and its subsidiary 1337 esports AB partners with Adventure Box to boost Kogama platform growth

Rightbridge Ventures Group AB (Publ) (“Rightbridge Ventures” or “Rightbridge”) has through its wholly owned subsidiary 1337 esports AB (“1337”) entered into a strategic partnership and consultancy agreement with Adventure Box Technology AB (“Adventure Box”), the company behind the popular social gaming platform Kogama. 1337 is appointed with the goal to accelerate Kogama's growth by structuring its media offering and creating new revenue opportunities and opportunities within the Rightbridge ecosystem. The agreement consists of a fixed fee for 1337 and a variable performance based fee.

Cereno Scientific releases Insights Videos Season 3 Episode 1–4 with Sten R. Sörensen, CEO, Cereno Scientific

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episodes 1- 4 of Season 3 in the Insights Video Series has been released. In the videos, recorded at the Pulmonary Vascular Research Institute (PVRI) Annual Congress 2024, CEO Sten R. Sörensen highlights the remarkable early signs of efficacy in Cereno Scientific’s Phase II study with candidate drug CS1 in patients with PAH, the importance of the “Compassionate Use”-approval for CS1 by the FDA, the potential of HDAC inhibition by CS1 and

Year-end bulletin Pharmacolog 2023

Press release: Uppsala, February 16, 2024 Pharmacolog i Uppsala AB (publ) year-end bulletin for the period January - December 2023 is now available on the company's website  and is attached as a pdf.Fourth quarter October 1 - December 31, 2023 · The Group's net sales for the fourth quarter amounted to KSEK 2 567 (1 785). · Operating profit for the quarter amounted to KSEK -4,159 (-6,763). · Net earnings per share for the quarter were SEK -0.06 (-0.36) before dilution and SEK -0.03 (-0.31) after dilution. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top